Burleson & Co’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$6.54K Hold
70
﹤0.01% 289
2022
Q3
$7K Hold
70
﹤0.01% 298
2022
Q2
$6K Buy
70
+1
+1% +$98 ﹤0.01% 286
2022
Q1
$7K Buy
69
+17
+33% +$1.79K ﹤0.01% 284
2021
Q4
$5K Hold
52
﹤0.01% 287
2021
Q3
$4K Buy
52
+1
+2% +$84 ﹤0.01% 292
2021
Q2
$4K Hold
51
﹤0.01% 298
2021
Q1
$4K Buy
+51
New +$3.71K ﹤0.01% 290

Other funds holding CVS

Burleson & Co's CVS Position: Q4 2022 in Review

Burleson & Co held its CVS Health (CVS) position steady in Q4 2022 at 70 shares worth $6.54K. The position accounts for ﹤0.01% of the portfolio, ranked #289.

Burleson & Co first reported a position in CVS in Q1 2021 and has held it in 8 quarters since. The position peaked at $7K in Q3 2022. 2,406 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Burleson & Co held 70 shares of CVS Health worth $6.54K as of Q4 2022.
  • Burleson & Co left its CVS Health share count unchanged in Q4 2022.
  • CVS Health made up ﹤0.01% of Burleson & Co's portfolio in Q4 2022, its #289 holding.
  • Burleson & Co first reported a position in CVS Health in Q1 2021 and has held it in 8 quarters since.
  • Burleson & Co's CVS Health position peaked at $7K in Q3 2022.
  • 2,406 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.